Rhonda Farnum

Chief Tech/Sci/R&D Officer at THERAVANCE BIOPHARMA, INC.

Net worth: 3 M $ as of 2024-05-30

59 year

Health Technology

Consumer Services

Active connections

Name	Gender	Age	Linked companies	Collaboration
Dean Mitchell	M	68	THERAVANCE BIOPHARMA, INC.	10 years
Eran Broshy	M	65	THERAVANCE BIOPHARMA, INC.	10 years
Deepa Pakianathan	M	59	THERAVANCE BIOPHARMA, INC.	4 years
Susannah Gray	F	63	THERAVANCE BIOPHARMA, INC.	1 years
Rick Winningham	M	64	THERAVANCE BIOPHARMA, INC.	11 years
Jim Kelly	M	43	THERAVANCE BIOPHARMA, INC.	1 years
Donal O'Connor	M	73	THERAVANCE BIOPHARMA, INC.	9 years
Laurie Alsup	M	70	THERAVANCE BIOPHARMA, INC.	6 years
Jeremy Grant	M	36	THERAVANCE BIOPHARMA, INC.	1 years
Richard Graham	M	-	THERAVANCE BIOPHARMA, INC.	-
Brett Grimaud	M	50	THERAVANCE BIOPHARMA, INC.	3 years
Aziz Sawaf	M	42	THERAVANCE BIOPHARMA, INC.	10 years
Aine Miller	M	47	THERAVANCE BIOPHARMA, INC.	-
Stacy Pryce	F	-	THERAVANCE BIOPHARMA, INC.	-
Stuart Knight	M	-	THERAVANCE BIOPHARMA, INC.	10 years

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Pablo Cagnoni	M	60	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	2 years
Susan Molineaux	M	70	THERAVANCE BIOPHARMA, INC.	7 years
Gail B. Cohen	F	-	THERAVANCE BIOPHARMA, INC.	2 years
Sriram Ryali	M	43	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	4 years
Renée Galá	F	52	THERAVANCE BIOPHARMA, INC.	5 years
Brett K. Haumann	M	54	THERAVANCE BIOPHARMA, INC.	7 years
Asif Ali	M	50	THERAVANCE BIOPHARMA, INC.	4 years
Robert Gunderson	M	72	THERAVANCE BIOPHARMA, INC.	8 years
Peter S. Ringrose	M	78	THERAVANCE BIOPHARMA, INC.	7 years
George M. Whitesides	M	84	THERAVANCE BIOPHARMA, INC.	8 years
Bradford J. Shafer	M	63	THERAVANCE BIOPHARMA, INC.	7 years
William Young	M	79	THERAVANCE BIOPHARMA, INC.	10 years
Burt Malkiel	M	90	THERAVANCE BIOPHARMA, INC.	11 years
Sujay Kango	M	60	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	4 years
Kanya Rajangam	M	50	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	4 years
Alexander Dobbin	M	-	THERAVANCE BIOPHARMA, INC.	3 years
Shehnaaz Suliman	M	52	THERAVANCE BIOPHARMA, INC.	2 years
Barbara Klencke	M	66	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	4 years
Vijay Sabesan	M	51	THERAVANCE BIOPHARMA, INC.	7 years
Andrew Hindman	M	51	THERAVANCE BIOPHARMA, INC.	3 years
Rosh Dias	M	-	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	1 years
Francesco Galimi	M	56	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	1 years
Jeff Knight	M	52	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	3 years
Jane Chung	F	53	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	2 years
Dana Pizzuti	M	68	THERAVANCE BIOPHARMA, INC.	-
Bill Tan	M	-	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	1 years
Robert Goeltz	M	51	Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	2 years

Statistics

Country	Connections	% of total
United States	42	100.00%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections